|
DNAH14 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.25499999999546E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.797400E-03 |
| Normal-vs-Stage2 |
1.147230E-01 |
| Normal-vs-Stage3 |
1.685600E-02 |
| Normal-vs-Stage4 |
1.803990E-01 |
| Stage1-vs-Stage2 |
9.723600E-01 |
| Stage1-vs-Stage3 |
1.776800E-01 |
| Stage1-vs-Stage4 |
3.823600E-01 |
| Stage2-vs-Stage3 |
2.544600E-01 |
| Stage2-vs-Stage4 |
4.037200E-01 |
| Stage3-vs-Stage4 |
7.677000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.62890000002347E-06 |
| Normal-vs-AfricanAmerican |
1.769430E-01 |
| Normal-vs-Asian |
3.466000E-01 |
| Caucasian-vs-AfricanAmerican |
7.575600E-03 |
| Caucasian-vs-Asian |
6.915200E-01 |
| AfricanAmerican-vs-Asian |
4.440400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.857400E-03 |
| Normal-vs-Female |
1.08759999994934E-06 |
| Male-vs-Female |
2.398300E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.479100E-03 |
| Normal-vs-Extreme_Weight |
3.919700E-03 |
| Normal-vs-Obese |
2.263400E-03 |
| Normal-vs-Extreme_Obese |
1.065770E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.674400E-01 |
| Normal_Weight-vs-Obese |
8.099200E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.865000E-01 |
| Extreme_Weight-vs-Obese |
4.783600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.499800E-01 |
| Obese-vs-Extreme_Obese |
7.724200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.107810E-01 |
| Normal-vs-Age(41-60Yrs) |
5.50879999999809E-05 |
| Normal-vs-Age(61-80Yrs) |
1.637010E-03 |
| Normal-vs-Age(81-100Yrs) |
8.464600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.752800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.956000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.275020E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.547020E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.897370E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.616500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.422900E-04 |
| Normal-VS-Type2 PRCC |
4.464900E-03 |
| Normal-VS-KIRP CIMP |
2.534600E-01 |
| Normal-VS-Unclassified PRCC |
1.328420E-02 |
| Type1 PRCC-VS-Type2 PRCC |
3.807000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.039000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.813400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.812000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.320800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.413600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.334100E-02 |
| Normal-vs-N1 |
1.233830E-02 |
| Normal-vs-N2 |
2.679200E-01 |
| N0-vs-N1 |
7.451900E-02 |
| N0-vs-N2 |
1.490640E-01 |
| N1-vs-N2 |
9.604800E-01 |
|
|
